0.992

0.80% -0.008

Pre-market: 1.07 0.078 +7.86%

Cardiol Therapeutics Inc (CRDL)

Overview News Price History Option Chain Why CRDL Down? Discussions Forecast

Cardiol Therapeutics Inc stock is traded at $0.992, with a volume of 325.73K. It is down -0.80% in the last 24 hours and down -8.15% over the past month. Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Previous Close:

$1.00

Open:

$1.01

24h Volume:

325.73K

Relative Volume:

0.68

Market Cap:

$114.35M

Revenue:

Net Income/Loss:

$-26.33M

P/E Ratio:

-3.5127

EPS:

-0.2824

Net Cash Flow:

$-17.65M

1W Performance:

-5.52%

1M Performance:

-8.15%

6M Performance:

-0.53%

1Y Performance:

-28.63%

1-Day Range:

$0.99

$1.02

1-Week Range:

$0.98

$1.105

52-Week Range:

$0.88

$1.71

Cardiol Therapeutics Inc Stock (CRDL) Company Profile

Name

Cardiol Therapeutics Inc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CRDL's Discussions on Twitter

Compare CRDL vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRDL Cardiol Therapeutics Inc	0.992	114.35M	0	-26.33M	-17.65M	-0.2824
TAK Takeda Pharmaceutical Co Adr	16.61	53.04B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.71	42.76B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	33.10	38.54B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.08	31.48B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	552.48	23.45B	3.17B	1.29B	1.01B	27.09

Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Initiated	H.C. Wainwright	Buy
Jan-28-25	Initiated	Rodman & Renshaw	Buy
Jun-26-24	Initiated	ROTH MKM	Buy
Apr-22-24	Initiated	H.C. Wainwright	Buy

Cardiol Therapeutics Inc Stock (CRDL) Latest News

Jul 09, 2026

Cardiol Therapeutics (CRDL) to Attend B. Riley Securities Summit in Boston - GuruFocus

Jul 09, 2026

Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit - TipRanks

Jul 09, 2026

Cardiol Therapeutics (CRDL) to present CardiolRx™ pipeline at B. Riley Mind, Muscle & Vision Summit - Stock Titan

Jul 09, 2026

CRDL Q1 2026 Earnings: Narrower-than-Expected Loss as Cardiol Therapeutics Advances PipelineReturn On Equity - dars.gov.et

Jul 02, 2026

CRDL Stock Price, Quote & Chart - ChartMill

Jul 02, 2026

Jun 29, 2026

Enterprise value to revenue forward of Cardiol Therapeutics Inc. – BOATS:CRDL - TradingView

Jun 29, 2026

Jun 27, 2026

CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 27, 2026

Price to earnings forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView

Jun 27, 2026

Enterprise value to revenue forward of Cardiol Therapeutics Inc. Class A – TSX:CRDL - TradingView

Jun 27, 2026

Jun 26, 2026

Cardiol Therapeutics Inc. Class A Actuals & Estimates (TSX:CRDL) - TradingView

Jun 26, 2026

Cardiol Therapeutics Inc. Class A Actuals & Estimates (NEO:CRDL) - TradingView

Jun 26, 2026

Jun 25, 2026

CRDL Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Cardiol Therapeutics Inc. - Mena FN

Jun 25, 2026

Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail

Jun 25, 2026

Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM - TipRanks

Jun 25, 2026

A2PA9E Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Strong shareholder support at Cardiol Therapeutics (CRDL) 2026 AGM as all directors elected - Stock Titan

Jun 25, 2026

Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders - PR Newswire

Jun 25, 2026

Jun 23, 2026

Why Cardiol Therapeutics Inc Class A stock is rising today - Wealth Awesome

Jun 23, 2026

Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance - TipRanks

Jun 23, 2026

Form 6K Cordel Group PLC For: 23 June By Investing.com - Investing.com India

Jun 23, 2026

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT - PR Newswire

Jun 23, 2026

Jun 22, 2026